What is the share price of PEL in NSE?
Piramal Enterprises Limited (traded on the National Stock Exchange of India under the ticker PEL) operates as a prominent diversified non-banking financial company and healthcare enterprise. While specific real-time tick values fluctuate throughout trading sessions, its valuation is driven by retail and wholesale lending growth, asset quality metrics, provisioning coverage, pharmaceuticals portfolio performance, capital allocation strategies, and prevailing interest rate cycles set by the central bank. Investors evaluate its financial health through quarterly earnings disclosures, regulatory compliance, and overall performance indicators across Indian financial services equities.
Related FAQs
Piramal Enterprises Limited establishes specific record dates for its corporate distributions and dividend announcements in compliance with stock exchange guidelines.
Anand Piramal is the son of billionaire industrialist Ajay Piramal and serves as the son-in-law of billionaire business tycoon Mukesh Ambani, having married his daughter Isha Ambani in a high-profile wedding.
When a company's shares are suspended from trading on a stock exchange, buying and selling of that equity is temporarily frozen.
Evaluating whether Piramal Pharma Limited represents an attractive purchase involves analyzing its recovery potential within the global pharmaceutical outsourcing and domestic formulations market.
Institutional brokerages tracking Piramal Enterprises and its financial services segments establish a 12-month consensus target price averaging around Rs 1,015 for 2026, with prominent financial firms like JM Financial indicating neutral targets near...
Anand Piramal is a prominent Indian businessman belonging to the wealthy Piramal family, which controls the diversified Piramal Group conglomerate spanning pharmaceuticals, financial services, and real estate.
The merger ratio for any corporate transaction involving a company designated by the ticker PEL depends entirely on the specific consolidation or acquisition agreement under review.
Piramal Enterprises Limited (PEL) shares have experienced active trading on Indian stock exchanges like the NSE and BSE, reflecting the company's strategic evolution as a diversified non-banking financial company.
Corporate merger ratios involving entities abbreviated as PEL and PFL depend on the specific corporate restructuring agreements announced by the respective companies.
Piramal Finance possesses a strong future growth outlook supported by robust loan book expansions across retail, micro-entrepreneur, and affordable housing segments in India.
Evaluating whether Piramal Enterprises represents a strong long-term investment requires analyzing its strategic business transition into a diversified non-banking financial company focusing on retail lending, wholesale funding, and alternative asset...
Piramal Enterprises anticipates a progressive future financial outlook shaped by its strategic transformation into a diversified, digitally enabled non-banking financial corporation in India.
Piramal Enterprises Limited advanced its strategic corporate transformation into a specialized non-banking financial services entity following the complete demerger of its pharmaceutical operations.
Shareholders holding equity in Piramal Enterprises experience value shifts dictated by the company's strategic evolution across financial services, pharmaceutical investments, and lending portfolios.
Piramal and its founding family possess substantial industrial and financial wealth amassed over decades through pharmaceutical, real estate, and financial services ventures, but they do not approach the multi-billion-dollar net worth commanded by Mu...
Piramal Enterprises Limited (PEL) shares have experienced active trading on major Indian stock exchanges, driven by the company's continuous structural transformation into a specialized non-banking financial services entity.
Piramal Enterprises Limited (PEL) maintains its stock market listing under the ticker symbol PEL while executing major internal corporate restructurings and business consolidations, including the integration of Piramal Finance operations.
Piramal Enterprises Limited (PEL) executed a major long-term corporate evolution, transitioning away from a traditional manufacturing conglomerate model to establish a pure-play, diversified financial services powerhouse.
Piramal Enterprises Limited, a prominent diversified business conglomerate spanning healthcare, financial services, and real estate, evolved through a complex series of corporate name changes reflecting its strategic pivots.